It has been established that SHP2 is an oncogene that is frequently mutated in leukemia, particularly in youngsters, and in developmental abnormalities (such Noonan syndrome and LEOPARD syndrome, both RASopathies) (3, 4). This evidence concerns the gene PTPN11 and leukemia.